Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1097/MD.0000000000005974 | ||||
| Año | 2017 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
AOM in Chilean children is predominantly caused by Streptococcus pneumoniae and nontypeable Haemophilus influenzae. Use of a broad spectrum vaccine against these pathogens might aid the reduction of AOM in Chile.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Rosenblut, Andres | Hombre |
Hospital Dr Sotero del Rio - Chile
|
| 2 | Napolitano, Carla | Mujer |
Hospital Dr Sotero del Rio - Chile
|
| 3 | Pereira, Angelica | Mujer |
Hospital Dr Sotero del Rio - Chile
|
| 4 | Moreno, Camilo | Hombre |
Merck & Co Inc - Brasil
Takeda Pharmaceut - Brasil Merck and Co. - Brasil Takeda Pharmaceuticals - Brasil |
| 5 | Kolhe, Devayani | - |
GSK Pharmaceut Ltd - India
GlaxoSmithKline Pharmaceuticals Ltd. - India GlaxoSmithKline plc. - Reino Unido |
| 6 | Lepetic, Alejandro | Hombre |
GSK Buenos Aires - Argentina
GSK Buenos - Argentina GlaxoSmithKline plc. - Argentina |
| 7 | Ortega-Barria, Eduardo | Hombre |
GSK Panama - Panamá
GlaxoSmithKline plc. - Reino Unido GlaxoSmithKline plc. - Argentina |
| Agradecimiento |
|---|
| This study was sponsored by GlaxoSmithKline Biologicals SA (etrack: 112671). GlaxoSmithKline Biologicals SA also funded all costs associated with the development of the manuscript. |
| This study was sponsored by GlaxoSmithKline Biologicals SA (etrack: 112671). GlaxoSmithKline Biologicals SA also funded all costs associated with the development of the manuscript. |